STAT3 and breast carcinoma: In breast cancer, IL-6 is known to activate STAT3, which has been shown to be an important signaling molecule that is associated with an unfavorable prognosis; in fact, the principal mechanism of STAT3 activation is via the IL-6/gp130/Jak pathway [50].